Literature DB >> 25003300

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer.

Francis M Giardiello1, John I Allen, Jennifer E Axilbund, C Richard Boland, Carol A Burke, Randall W Burt, James M Church, Jason A Dominitz, David A Johnson, Tonya Kaltenbach, Theodore R Levin, David A Lieberman, Douglas J Robertson, Sapna Syngal, Douglas K Rex.   

Abstract

The Multi-Society Task Force, in collaboration with invited experts, developed guidelines to assist health care providers with the appropriate provision of genetic testing and management of patients at risk for and affected with Lynch syndrome as follows: provides a colorectal cancer risk assessment tool to screen individuals in the office or endoscopy setting; illustrates a strategy for universal screening for Lynch syndrome by tumor testing of patients diagnosed with colorectal cancer; -6 provide algorithms for genetic evaluation of affected and at-risk family members of pedigrees with Lynch syndrome; provides guidelines for screening at-risk and affected persons with Lynch syndrome; and lists the guidelines for the management of patients with Lynch syndrome. A detailed explanation of Lynch syndrome and the methodology utilized to derive these guidelines, as well as an explanation of, and supporting literature for, these guidelines are provided.

Entities:  

Mesh:

Year:  2014        PMID: 25003300     DOI: 10.1097/DCR.000000000000000

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  25 in total

1.  A model for patient-direct screening and referral for familial cancer risk.

Authors:  Kristin B Niendorf; Melissa A Geller; Rachel Isaksson Vogel; Timothy R Church; Anna Leininger; Angela Bakke; Robert D Madoff
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

2.  Patterns of family communication and preferred resources for sharing information among families with a Lynch syndrome diagnosis.

Authors:  Jenna Petersen; Cathryn Koptiuch; Yelena P Wu; Ryan Mooney; Ashley Elrick; Kathryn Szczotka; Megan Keener; Lisa Pappas; Priyanka Kanth; Andrew Soisson; Wendy Kohlmann; Kimberly A Kaphingst
Journal:  Patient Educ Couns       Date:  2018-07-26

3.  Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer.

Authors:  Aparna R Parikh; Nancy L Keating; Pang-Hsiang Liu; Stacy W Gray; Carrie N Klabunde; Katherine L Kahn; David A Haggstrom; Sapna Syngal; Benjamin Kim
Journal:  J Oncol Pract       Date:  2016-03       Impact factor: 3.840

Review 4.  Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma.

Authors:  Jinru Shia
Journal:  Semin Diagn Pathol       Date:  2015-02-04       Impact factor: 3.464

Review 5.  The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment.

Authors:  Louise C Connell; José Mauricio Mota; Maria Ignez Braghiroli; Paulo M Hoff
Journal:  Curr Treat Options Oncol       Date:  2017-04

Review 6.  Milestones of Lynch syndrome: 1895-2015.

Authors:  Henry T Lynch; Carrie L Snyder; Trudy G Shaw; Christopher D Heinen; Megan P Hitchins
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

Review 7.  Translational Research in Familial Colorectal Cancer Syndromes.

Authors:  Molly M Ford
Journal:  Clin Colon Rectal Surg       Date:  2018-05-01

8.  Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008.

Authors:  Nicholas Donin; Christopher Filson; Alexandra Drakaki; Hung-Jui Tan; Alex Castillo; Lorna Kwan; Mark Litwin; Karim Chamie
Journal:  Cancer       Date:  2016-07-05       Impact factor: 6.860

9.  Unusual case of anorexia.

Authors:  Laura Darmaun; Estelle Aubry; Sophie Lejeune; Helene Sudour-Bonnange
Journal:  BMJ Case Rep       Date:  2018-06-04

10.  The Experience of Extended Bowel Resection in Individuals With a High Metachronous Colorectal Cancer Risk: A Qualitative Study.

Authors:  Emma J Steel; Alison H Trainer; Alexander G Heriot; Craig Lynch; Susan Parry; Aung K Win; Louise A Keogh
Journal:  Oncol Nurs Forum       Date:  2016-07-01       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.